How much do harm reduction tools like naloxone and syringe access actually reduce deaths, and how does that evidence stack up against faith-based and abstinence-focused approaches?
The debate surfaced when Health and Human Services Secretary Robert F. Kennedy Jr. said harm reduction “doesn’t work” while announcing a shift in federal priorities toward faith and spirituality in recovery.
For anyone comparing addiction treatment options, the more useful question isn’t who is right politically, but what the data actually shows about outcomes.
What the Evidence Shows About Harm Reduction
Michigan offers one of the more direct data points in this debate. According to Bridge Michigan, the state has spent much of its opioid settlement funding on harm reduction tools, including naloxone (commonly known as Narcan) and fentanyl test strips, alongside prevention, treatment and recovery spending.
State officials have credited that spending, at least in part, with pushing drug deaths to their lowest level in a decade.
That outcome data doesn’t settle every question. Harm reduction spending was one of four funding pillars, alongside treatment and recovery, so isolating its individual effect is difficult.
But it does complicate a blanket claim that harm reduction “doesn’t work,” since the state that leaned into it saw deaths fall.
What the Research Says About Faith and Recovery
The federal shift also leans on the idea that faith-based and spiritual approaches are an underused alternative. Here, too, existing research tells a more nuanced story than “either/or.”
A 2019 review published in the peer-reviewed Journal of Religion and Health found that the vast majority of addiction treatment and recovery programs in the U.S. already incorporate some sense of spirituality or a higher power, whether or not they are formally labeled faith-based.
That finding suggests spirituality and clinical, evidence-based treatment are not competing camps so much as they are already overlapping in most programs.
It also means that someone who wants a treatment path with a spiritual component already has many options, without necessarily giving up medical or clinical elements of care.
Where the Research Is Clear: Medication for Opioid Use Disorder
One place the evidence base is not ambiguous is medication for opioid use disorder. Methadone and buprenorphine, both considered harm reduction tools by organizations like American Addiction Centers, reduce cravings and withdrawal symptoms and are strongly supported by clinical research.
Notably, Kennedy said federal support for both medications will continue even as other harm reduction programs lose funding, an acknowledgment that this particular evidence base remains solid regardless of the broader policy shift.
What This Means for Treatment Seekers
If you’re researching rehab right now, the underlying research supports a mixed approach rather than picking a single ideology.
Medication-assisted treatment (MAT) for opioid use disorder has strong evidence behind it, harm reduction tools have state-level outcome data behind them, and spiritually informed care is already woven into most treatment programs.
The best fit is usually the program that combines the elements relevant to your situation, not the one that claims to be the only approach that works.
Exploring Treatment Options
Rehab.com’s directory includes verified treatment centers that utilize harm reduction tools to support your recovery. Call
800-985-8516
( 
Sponsored Helpline )
to speak with a treatment specialist today.
